Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,780.40
(
-0.07%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.36
(
-2.08%
)
Bitcoin
70,451.20
(
-1.11%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

caravon

Send PM Follow Ignore
Followers 12
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

caravon

Re: spartex post# 44337

Wednesday, 04/04/2007 9:19:31 PM

Wednesday, April 04, 2007 9:19:31 PM

Post# of 257262
These are my final arguments:

It is a very well known fact that good many drugs have done very good in small PhII trials and then failed miserably in large PhIII trials.

Furthermore, IMHO, DNDN's trial in question has been designed and executed in a way leaving plenty of room for data manipulation and misinterpretation.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now